LIBTAYO 350 mg concentrate for solution for infusion., matching Placebo with R2810
R2810-ONC-1788
Phase 3 small_molecule active
Quick answer
LIBTAYO 350 mg concentrate for solution for infusion., matching Placebo with R2810 for Cutaneous Squamous Cell Carcinoma (CSCC) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Cutaneous Squamous Cell Carcinoma (CSCC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active